making stem cells from differentiated cells!
the state of the art to most is high throughput screening. Our approach is to identify signals cells use to coordinate towards the shared goal of ‘be cell type x now’ so that we might achieve a more effective outcome.
typically reprogramming is <1% effective.
Improving this yield is a key bottleneck to translating this technology for regenerative medicine applications and aging